Cas:76002-91-0 bisphenol a (2 3-dihydroxypropyl) glycid manufacturer & supplier

Chemical Name:bisphenol a (2 3-dihydroxypropyl) glycid

CAS.NO:76002-91-0

Synonyms:3-(4-(1-(4-(2,3-Epoxypropoxy)phenyl)-1-methylethyl)phenoxy)propane-1,2-diol;BADGE-H2O;EINECS 278-357-9;3-(4-{2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl}phenoxy)propane-1,2-diol;2-[4-(2,3-epoxypropanyloxy)phenyl-2-4-(2,3-dihydroxypropanyloxy)phenyl]propane;2-[4-(2,3-Dihydroxypropyloxy)phenyl]-2-[4-(glycidyloxy)phenyl]propane;Bisphenol A (2,3-dihydroxypropyl) glycidyl ether

Molecular Formula:C₂₁H₂₆O₅

Molecular Weight:358.42800

HS Code:2910900090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:553ºC at 760 mmHg

Density:1.197g/cm3

Index of Refraction:1.574

PSA:71.45000

Exact Mass:358.17800

LogP:2.52210

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 3-(4-(1-(4-(2,3-Epoxypropoxy)phenyl)-1-methylethyl)phenoxy)propane-1,2-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bisphenol A (2,3-dihydroxypropyl) glycidyl ether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[4-(2,3-epoxypropanyloxy)phenyl-2-4-(2,3-dihydroxypropanyloxy)phenyl]propane Use and application,2-[4-(2,3-Dihydroxypropyloxy)phenyl]-2-[4-(glycidyloxy)phenyl]propane technical grade,usp/ep/jp grade.

Related News: Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. bisphenol a (2 3-dihydroxypropyl) glycid manufacturer The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally. bisphenol a (2 3-dihydroxypropyl) glycid supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. bisphenol a (2 3-dihydroxypropyl) glycid vendor Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. bisphenol a (2 3-dihydroxypropyl) glycid factory The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.